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revealed significantly higher skin penetration rates than 
larger sized HA associated with increased expression of 
genes and proteins known to be involved in tight junction 
formation and keratinocyte cohesion.  Conclusion: LMW HA 
of approximately 50 kDa shows better penetration abilities 
than larger-sized HA. In addition, LMW HA influences the ex-
pression of various genes including those contributing to ke-
ratinocyte differentiation and formation of intercellular tight 
junction complexes without showing proinflammatory ac-
tivity. These observations contribute to current knowledge 
on the effects of LMW HA on keratinocyte biology and cuta-
neous physiology.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Hyaluronic acid (HA) represents a naturally occurring 
glycosaminoglycan biopolymer, located mostly in the in-
tercellular matrix of the dermis but has also been found in 
the epidermal layer of the skin  [1] . Its molecular structure 
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 Abstract 
 Background: Due to its strong water binding potential, hy-
aluronic acid (HA) is a well-known active ingredient for cos-
metic applications. However, based on its varying molecular 
size, skin penetration of HA may be limited. Recent studies 
have demonstrated that low-molecular-weight HA (LMW 
HA) may show a certain proinflammatory activity. We thus 
aimed to characterize an LMW-sized HA molecule that com-
bines strong anti-aging abilities with efficient skin penetra-
tion but lacks potential proinflammatory effects.  Methods: 
Total RNA and total protein were isolated from reconstituted 
human epidermis following incubation with HAs of various 
molecular weights (20, 50, 130, 300, 800 and 1,500 kDa). Tu-
mor necrosis factor-  expression was determined using 
quantitative PCR. Genomic and proteomic expression of var-
ious junctional proteins was determined using Affymetrix 
and common Western blotting techniques.  Results: LMW 
 HA of approximately 50 kDa did not significantly alter tumor 
necrosis factor-  expression compared to 20-kDa HA, but 
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is highly conserved between mammalian species  [2, 3] . 
HA represents one of the major matrix substances in which 
cells and fibrous constituents of the dermal matrix includ-
ing collagen and elastin are embedded  [4] . Its invariant 
chemical structure reduces the likelihood of immunologic 
reactions, thus increasing its biocompatibility. HA mole-
cules are also known to significantly contribute to the 
maintenance of the extracellular space. Due to their enor-
mous water-binding capacity, HA molecules are highly 
relevant in controlling tissue hydration  [5, 6] . Additionally, 
HA seems to play a pivotal role in tissue regeneration since 
recent studies suggest that the integrity and balance of ma-
trix components themselves, which undergo degradation 
and reconstruction, assure normal tissue function and 
contribute to the regulation of wound healing  [7, 8] . Be-
sides being commonly utilized as an attractive therapeutic 
agent in medical fields such as ophthalmology and rheu-
matology, its extraordinary properties make HA a promis-
ing candidate for a variety of cosmetic applications, par-
ticularly in the context of skin regeneration, tissue aug-
mentation and other anti-aging treatments  [3] . However, 
this plethora of potential beneficial features is limited by 
the molecular size of HA, which can reach up to 2,000 
kDa, thus interfering with efficient skin penetration.
 This phenomenon may easily be addressed by frag-
mentation of high-molecular-weight HA. However, re-
cent studies have shown that low-molecular-weight 
(LMW) HA or HA fragments may be involved in various 
biological processes including cell proliferation, angio-
genesis, migration, maturation, activation of protein ty-
rosine cascades and proinflammatory activity  [9–11] . In 
a study by Voelcker et al. [12] , HA fragments were recog-
nized by so-called Toll-like receptors (TLRs) 2 and 4 on 
human melanoma cells leading to activation of these cells 
and thus production of proinflammatory mediators.
 In the present study, we thus aimed to identify an 
LMW HA molecule that combines strong anti-aging and 
moisturizing abilities with efficient skin penetration but 
lacks the proinflammatory effects mediated by TLRs.
 Materials and Methods 
 Material 
 HA was produced using a novel, solvent-free methodology 
based on a new fermentation strain of  Bacillus subtilis . This fer-
mentation process results in a protein-free HA with constant mo-
lecular weight that appears as a very fine powder after the process 
of spray drying.
 LMW HA is produced by controlled thermal hydrolysis of 
high-molecular-weight HA. Briefly, the HA powder containing 
residual humidity is heated up to 120–130  °  C for different periods 
of time, and hydrolysis is performed under controlled conditions 
until specifications of viscosity are achieved.
 Methods 
 In vitro Culturing of Reconstituted Human Epidermis 
Constructs in the Presence of HA  
 Reconstituted human epidermis was purchased from Skin-
Ethic (Nice, France) and incubated for 24 h in standard mainte-
nance medium at 37   °   C and 5% CO 2 as previously described  [13] 
before starting the experiments. In total, three different types of 
experiments employing reconstituted human epidermis con-
structs treated with various molecular weight forms of HA were 
conducted. In order to evaluate the possible proinflammatory ef-
fects of very LMW (VLMW) HA, the reconstituted human epi-
dermis was incubated for 48 h with 50   l phosphate-buffered sa-
line (PBS) containing 0.5% 20-, 50-, 130- or 320-kDa HA, respec-
tively. PBS-treated reconstituted human epidermis served as 
control. After incubation, RNA was isolated and served as tem-
plate for cDNA generation. Using quantitative RT-PCR, the ex-
pression of the proinflammatory cytokine tumor necrosis factor-
  (TNF-  ) was determined.
 Another set of experiments was performed to characterize the 
effects of HA on keratinocytes on a molecular level. In this con-
text, reconstructed human epidermis was treated topically with 
50   l of a thin liquid O/W emulsion (composition: 3% glyceryl 
stearate-ceteth-20; 1% stearyl alcohol; 4% cetearyl ethylhexano-
ate; 4% caprylic/capric triglyceride; pH adjusted to 6 with NaOH; 
water: ad. 100%) containing 0.5% of 50-kDa HA and 800-kDa 
HA, 0.2% retinol as positive control or not active at all as vehicle 
control. The emulsion type vehicle was chosen because retinol is 
insoluble in water. Retinol was dissolved in the oil phase, whereas 
HA was dissolved in the water phase. Following 48 h application, 
RNA was extracted for transcriptome analysis using microarray 
technique and TaqMan  RT-PCR assays (see below).
 A third set of experiments using reconstituted human epider-
mis constructs was conducted in order to confirm some of the 
observations from the microarray study on the protein level. 
Therefore, the models were topically treated with 0.05 and 0.5% 
50-kDa HA (commercially available as HyaCare  50) dissolved in 
water for 72 h (n = 4). Afterwards, protein extracts were prepared 
and used for Western blotting analysis (see below).
 In order to determine penetration properties of differentially 
sized HA molecules, diffusion of tritiated HA with a molecular 
weight of about 50, 300, 800 or 1,500 kDa through dermatomed 
porcine ear skin was assessed using Franz diffusion cells as previ-
ously described  [14] . In brief, full-thickness skin samples of visu-
ally intact skin from the ear of 5-month-old female domestic pigs 
were dermatomed to a thickness of about 750   m using an Accu-
lan GA 643 (Aesculap, Tuttlingen, Germany). The samples were 
then mounted in modified Franz static dermal penetration cells 
with the external surface of the stratum corneum facing the donor 
chamber. After 5 and 22 h of HA application, the level of radioac-
tivity in the receptor phase was determined and expressed as 
ng  cm –2  h –1 , which served as a parameter for skin penetration.
 RNA Isolation 
 Total RNA was extracted from cultured skin constructs using 
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s recommendations. RNA concentration was as-
sessed spectroscopically using SmartSpec Plus (Biorad, München, 
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Germany). Purity and integrity of the RNA was determined by an 
Agilent 2100 bioanalyzer with a 6000 Nano LabChip reagent set 
(Agilent Technologies, Santa Clara, Calif., USA). RNA samples 
were stored at –80  °  C until analysis.
 Quantitative RT-PCR 
 Reverse transcription was performed using the First-Strand 
cDNA Synthesis Kit (Super Script III, Invitrogen, Life Technolo-
gies, Carlsbad, Calif., USA) according to the guidelines of the 
manufacturer starting with 100 ng purified RNA from each sam-
ple. Quantitative PCR was carried out with an Opticon DNA en-
gine (MJ Research, Waltham, Mass., USA) using SYBR Green 
PCR Master Mix (Applied Biosystems, Darmstadt, Germany) ac-
cording to the manufacturer’s instructions. The following gene-
specific primers were used for TNF-  : forward 5  -CTG TGG 
CCC AGG CAG TCA GA-3  and reverse 5  -GGC GTT TGG GAA 
GGT TGG AT-3  . Glycerin aldehyde phosphate dehydrogenase 
(GAPDH) served as a housekeeping gene with the following prim-
er pair: forward 5  -ACC ACA GTC CAT GCC ATC AC-3  and 
reverse 5  -TCC ACC ACC CTG TTG CTG TA-3  .
 DNA Microarray and Data Analysis 
 Gene expression profiles were determined using Affymetrix 
HGU133 plus 2.0 GeneChips (Affymetrix, Santa Clara, Calif., 
USA) using 2   g of total RNA pooled from three reconstituted 
human epidermis skin models. Gene chip assays and initial anal-
ysis were carried out as previously described  [15] .
 TaqMan RT-PCR Assays 
 TaqMan first-strand cDNA synthesis was performed with the 
reverse transcription system from Promega (Madison, Wisc., 
USA) according to the manufacturer’s instructions. Real-time 
RT-PCR analysis was performed with an ABI7900HT machine 
(Applied Biosystems). All reagents necessary for running Taq-
Man  RT-PCR assays, including primers and probes were 
 purchased from Applied Biosystems and used according to the 
manufacturer’s    instructions.    TaqMan    analysis    of    transcripts 
for    CALB1   (Hs01077193_m1),   CLDN4   (Hs00533616_s1), 
CLDN7 (Hs00600772_m1), CLDN17 (Hs00273276_s1), OCLN 
(Hs00170162_m1), TJP2 (Hs00178081_m1) and 18S-rRNA 
(Hs99999901_s1) as endogenous control, was performed with 
predesigned and optimized Assays on Demand (Applied Biosys-
tems). The reaction parameters were as follows: 2 min 50  °  C hold, 
10 min 95   °   C hold, followed by 40 cycles of 10 s 95   °   C melt and 
1 min 60   °   C annealing and extension. Measurements were per-
formed in triplicate for both donors. Results were analyzed with 
an ABI sequence detector software version 2.0 (Applied Biosys-
tems). Relative quantification was performed using 18S-rRNA as 
reference as described earlier  [16] .
 Western Blotting 
 In order to confirm the observed genomic changes on a pro-
tein level, reconstructed human epidermis models (SkinEthic) 
were topically treated with 0.05 and 0.5% 50-kDa HA for 72 h 
(n = 4). Then, proteins were extracted using standard protocols 
and 20   g of the resulting supernatant was run out on a 4–20% 
SDS-polyacrylamide gel and subsequently electrotransferred to 
immune-blot PVDF membranes (Bio-Rad Laboratories, Hercu-
les, Calif., USA). PVDF membrane sheets were then probed with 
primary antibody against tight junction protein-1 (TJP-1; BD Bio-
science, Franklin Lake, N.J., USA), tight junction protein-2 (TJP-
2; Santa Cruz Biotechnology, Calif., USA), E-cadherin (BD Bio-
science),   -catenin (BD Bioscience), occludin (Santa Cruz Bio-
technology), claudin-4 (Santa Cruz Biotechnology), claudin-17 
(Abcam, Cambridge, Mass., USA), claudin-1 (Santa Cruz Bio-
technology) and GAPDH (Abcam). The signals were then detect-
ed using horseradish peroxidase-conjugated secondary antibody, 
developed with chemiluminescent substrates (Pierce Biotechnol-
ogy, Rockford, Ill., USA) and were quantified with a density scan 
(Lumi-Imager TM F1, Roche Diagnostics, Mannheim, Germany). 
After quantification, the intensities of the protein signals were 
normalized to the respective GAPDH signals.
 Statistical Analysis 
 Results are presented as mean  8 SEM (n = 3 per group, at each 
time point, if not stated differently). The data were analyzed using 
one-way ANOVA and Kruskal-Wallis test, and differences were 
considered significant at a p value of  ! 0.05.
 Results 
 VLMW HA Is Associated with an Increased 
Proinflammatory Response  
 VLMW HA with a molecular weight of 20 kDa re-
vealed markedly increased expression of TNF-  (7.7  8 
6.9) in reconstructed epidermis models compared to 
models treated with PBS or HA molecules of higher mo-
lecular weight (1  8 0.5; 1.8  8 1.0; 2.7  8 2.3 and 0.58  8 
0.6, HA 50, 130 and 320 kDa, respectively), indicating a 
proinflammatory effect of VLMW HA ( fig. 1 ). In con-
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 Fig. 1. VLMW HA is associated with an increased proinflamma-
tory response. Total RNA was isolated from reconstituted human 
epidermis following incubation with PBS or HA of various mo-
lecular weights for 48 h. TNF-  expression was determined using 
quantitative RT-PCR with GAPDH serving as endogenous control. 
Mean value of the target was divided by the mean value of the en-
dogenous control to obtain a normalized mean quantity per sam-
ple. Results shown represent n = 3 per group, as indicated in the 
main text. Bars represent means, error bars correspond to SEM.  
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trast, HA molecules with a molecular weight  1 50 kDa did 
not induce marked upregulation of TNF-  expression 
compared to controls ( fig. 1 ).
 LMW HA Reveals Improved Penetration
Properties Compared to HA with a Molecular
Weight of  1 300 kDa  
 HA molecules with different molecular weight, name-
ly 50, 300, 800 and 1,500 kDa, were tested for their abil-
ity to penetrate pig ear skin after 5 and 22 h of HA ap-
plication. As shown in  figure 2 , only small amounts of 
HA with a molecular weight of 300 kDa and more (19.8 
 8 10 and 22.8  8 8; 7.3  8 3 and 9.1  8 4.2; 2.9  8 0.8 
and 3.4  8 1 ngcm –2 h–1; HA 300, 800 and 1,500 kDa, 
respectively) penetrated the skin, as seen at 5 and 22 h 
of incubation. In contrast, LMW HA with only 50 kDa 
revealed markedly higher skin penetration compared to 
the one with 300-kDa HA (69.5  8 49.9 and 83.5  8 53.4 
ngcm– 2 h–1;  fig. 2 ). Within duration (5 vs. 22 h) of incu-
bation, the flux of HA remained constant over time.
 LMW HA Is Associated with Increased Expression 
of Genes Known to Be Involved in Keratinocyte 
Differentiation and Cohesion  
 LMW HA with a molecular size of 50 kDa markedly 
affected up- or downregulation of about 120 genes (data 
not shown) including key genes involved in keratinocyte 
regulation as well as genes that play important roles for 
their cohesion. In contrast, HA with a molecular weight 
of about 800 kDa only led to differential expression of 40 
genes (data not shown). A selection of up- or downregu-
lated genes and their associated functions is presented in 
 table 1 .
 In particular, incubation of reconstructed human epi-
dermis with 50-kDa HA for 48 h resulted in marked up-
regulation of calbindin-1, occludin, claudin-4, -7, and -17, 
TJP-2 compared to vehicle treatment ( table 1 ). Notably, 
upregulation of all these genes was less pronounced in the 
case of 800-kDa HA ( table 1 ).
 Due to the fact that RNA pooled from 3 biological rep-
licates was used for microarray studies, the obtained re-
sults were judged as an indication that tight junction con-
trol is modulated by application of 50-kDa HA. For fur-
ther verification, the results for selected targets were 
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 Fig. 2. LMW HA reveals improved penetrating properties com-
pared to HA with higher molecular weights. HA molecules with 
different molecular weights, namely 50, 300, 800 and 1,500 kDa, 
were tested for their ability to penetrate pig ear skin (expressed in 
ng  cm –2  h –1 ) following 5 ($) and 22 h ()) of HA incubation. Re-
sults shown represent n = 3 per group, as indicated in the main 
text. Bars represent means, error bars correspond to SEM.  
Table 1. E ffects of LMW HA with 50 kDa and HA with a molecu-
lar weight of 800 kDA on gene expression in reconstructed epi-
dermis: microarray analysis
Fold change vs. vehicle
HA 50 kDa HA 800 kDa
Junctional control
Occludin 3.4 2.0
Claudin-4 3.8 2.4
Claudin-7 7.5 2.8
Claudin-17 5.1 3.2
Aquaporin-3 2.3 2.0
Desmocollin-2 1.8 1.4
TJP-2 1.9 1.3
Striatin, calmodulin-binding protein 2.2 1.5
Kinesin family member C3 2.6 1.8
Differentiation/epidermis development
Kallikrein-6 3.8 3.3
Kallikrein-14 2.0 2.1
Repetin 4.6 2.3
Keratin-34 3.0 1.4
Forkhead box Q1 4.0 3.2
ATPase, Ca2+ transporting, type 2C, member 1 –2.2 –1.6
Ceramide kinase –2.5 –2.0
Small proline-rich protein-4 2.7 2.2
Biliverdin reductase A –1.9 –1.3
Mitogen-activated protein kinase kinase-1 2.1 1.5
Calbindin-1 11.3 4.4
S100 calcium-binding protein A12
(calgranulin C) 2.0 1.6
Others
Thrombospondin-1 3.0 2.6
Sirtuin 2.9 1.6
TIMP metallopeptidase inhibitor-3 2.2 1.8
Glutathione peroxidase-2 3.3 2.7
Heparin-binding EGF-like growth factor 3.4 2.2
Interleukin-10 receptor- –2.7 –2.0
Interleukin-18 –1.8 –1.9
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reproduced independently by quantitative real-time PCR 
(qRT-PCR) experiments, in this case without pooling and 
including statistical analysis. Results are shown in  ta-
ble 2 . In general, the qRT-PCR experiments confirmed 
the previous microarray results. With the exception of 
the occludin gene, all genes were upregulated by treat-
ment with 50- or 800-kDa HA, and the effects were gen-
erally more pronounced in case of 50-kDa HA. All genes 
except the one encoding TJP-2 proved significantly (p  ^  
0.05) upregulated by 50-kDa HA.
 LMW HA Is Associated with Increased Expression 
of Proteins Known to Be Involved in Keratinocyte 
Differentiation and Cohesion  
 In order to confirm the superior stimulatory effects 
of 50-kDa HA on gene expression also on the protein 
level, we conducted a series of Western blotting experi-
ments. Treatment of human epidermis models with 50-
kDa HA resulted in increased protein levels of a number 
of TJPs in a dose-dependent manner. Specifically, TJP1 
and TJP2 were found to be markedly increased after 72-
hour posttreatment. The observed increase was accom-
panied by induction of claudin-1, -4 and -17 as well as 
E-cadherin,   -catenin and occludin ( fig.  3 ). However, 
while incubation of human epidermis with 0.5% 50-kDa 
HA led to significant upregulation of TJP1, TJP2 and oc-
cludin, treatment with 0.05% 50-kDa HA did not sig-
nificantly alter the amount of the respective proteins 
( fig. 3 ).
Table 2. E ffects of LMW HA with 50 kDa and HA with a molecu-
lar weight of 800 kDA on gene expression in reconstructed epi-
dermis: qRT-PCR analysis
Target HA 50 kDa H A 800 kDa
fold change 
vs. vehicle
SD/p 
value
fold change 
vs. vehi cle
SD/p 
value
Calbindin-1 5.1 0.28/0.00 1.2 1.41/0.64
Claudin-4 3.0 0.27/0.01 3.2 0.42/0.04
Claudin-7 6.1 0.41/0.01 2.1 0.44/0.06
Claudin-17 3.7 0.52/0.04 2.2 0.45/0.14
TJP-2 1.5 0.92/0.06 1.3 0.22/0.01
Occludin 1.1 0.19/0.01 0.8 0.25/0.10
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 Fig. 3.  a LMW HA is associated with increased expression of proteins known to be involved in keratinocyte 
regulation and cohesion. Accumulation of TJP-1, TJP-2, claudin-1, -4 and -17 as well as E-cadherin,   -catenin 
and occludin was determined in reconstituted human epidermis harvested after 72 h of topical treatment with 
either 0.05 or 0.5% 50-kDa HA.  b Histograms depict intensities of the phosphorylated protein bands divided 
by the total form of the respective protein (n = 4). Bars represent means, error bars correspond to SEM.  *  p  ! 
0.05, statistical significance for every comparison between groups. 
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 Discussion 
 HA, first discovered in the vitreous humor of the eye 
in 1934  [17] and subsequently synthesized in vitro in 1964 
 [18] , consists of a basic unit of two sugars, glucuronic acid 
and N-acetylglucosamine, polymerized into large macro-
molecules of over 30,000 repeating units  [3] . Due to its 
enormous water-binding capacity and its beneficial ef-
fects on cell proliferation, migration and thus tissue re-
generation, HA has recently gained prominence in reju-
venative medicine as the injectable dermal filler of choice 
for the treatment of cutaneous lines and wrinkles  [3] . 
However, applicability and potential beneficial activity 
features of HA have been shown to be limited by the mo-
lecular size of HA, which may reach up to 2,000 kDa and 
thus may interfere with efficient skin penetration. In con-
trast, VLMW HA or HA fragments may be recognized by 
so-called TLRs potentially leading to production of pro-
inflammatory mediators  [12] . At sites of inflammation, 
HA molecules undergo rapid degradation due to massive 
production of hyaluronidases by infiltrating inflamma-
tory cells and bacterial invaders  [19] . These HA frag-
ments have been implicated in the process of injury and 
repair since they have been shown to activate inflamma-
tory cells such as macrophages and dendritic cells to ex-
press proinflammatory mediators and enzymes degrad-
ing extracellular matrix  [20–23] . Recent studies identi-
fied TLR-4 as the HA fragment binding receptor that 
links HA degradation and activation of inflammatory 
cells  [24, 25] . In this study, we thus aimed to characterize 
an LMW-sized HA molecule that combines strong anti-
aging and moisturizing abilities with efficient skin pen-
etration but misses the proinflammatory effects mediat-
ed by TRLs. By measuring TNF-  expression in reconsti-
tuted human epidermis after incubation with variedly 
sized LMW HA, we found that VLMW HA with a mo-
lecular weight of around 20 kDa led to marked upregula-
tion of TNF-  expression in keratinocytes, indicating an 
inductive effect on the inflammatory response. In con-
trast, HA molecules with a molecular weight of 50 kDa 
or more did not alter the TNF-  expression profile in 
these cells to a large extent. However, differences in TNF-
  expression may be due to penetration differences of the 
variedly sized HA molecules applied to the reconstituted 
human epidermis.
 Having shown that HA with a molecular weight of 50 
kDa and higher did not reveal proinflammatory activity 
in keratinocytes, we tested the penetrating properties of 
variedly sized LMW HA, namely 50, 300, 800 and 1,500 
kDa. It was observed that a significantly higher skin pen-
etration of 50-kDa HA molecules occurs compared to the 
ones with a molecular weight of 300-kDa HA and above. 
This indicates a relevant dependence of percutaneous 
transport on the HA molecular weight with a better per-
meation apparent for the lower-molecular-weight frac-
tions. The route for this penetration is unknown, but as 
the molecular weight is much too high for percutaneous 
absorption, a follicular route is highly likely. Various skin 
delivery systems have been discussed  [26] . Recent results 
on follicular penetration obtained at the Center for Ex-
perimental and Applied Cutaneous Physiology, Char-
ité  –  Universitätsmedizin Berlin, Germany, emphasize 
that the hair follicles represent a highly relevant and ef-
ficient penetration pathway and reservoir for topically 
applied substances  [27] . It has been demonstrated that the 
penetration depth of the particles can be influenced by 
their size resulting in the possibility of a differentiated 
targeting of specific follicular structures. In vitro mea-
surements on pig ear skin appear to be equal or even su-
perior for the analysis of follicular penetration, as com-
pared to in vitro investigations on excised human skin 
indicating the suitability of this porcine tissue as a model 
for human skin  [28, 29] .
 Having identified the smallest molecular size of HA 
that does not induce an inflammatory response but shows 
the best bioavailability within the range analyzed, we 
next aimed to characterize the molecular impact of a 
LMW HA of about 50 kDa on keratinocytes in compari-
son to a HA molecule with a molecular weight of 800 
kDa, which is a representation of the commonly utilized 
HA used as active ingredient in cosmetic preparations for 
years. Using transcriptome analysis, we found that incu-
bation of keratinocytes with LMW HA significantly af-
fected overall up- or downregulation of about 120 genes, 
in particular genes known to be involved in keratinocyte 
regulation as well as genes that play important roles for 
their cohesion. HA with a molecular weight of about 800 
kDa, in contrast, only induced differential expression of 
40 genes, whereas topical application of 0.5% retinol un-
der the same conditions changed the expression of about 
160 genes (data not shown). These findings demonstrate 
the high gene regulatory potential of LMW HA. The 
treatment specifically led to marked upregulation of a 
broad variety of different TJPs on a genomic and pro-
teomic level. TJPs comprise a novel group of integral 
membrane proteins necessary for cell-to-cell contacts 
and responsible for the barrier function in epithelial and 
endothelial cells in various tissues. The tight junction 
membrane domain contains at least three distinct pro-
teins, named occludin, claudin and junctional adhesion 
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molecule, all of which have been discussed to contribute 
to keratinocyte differentiation and formation of intercel-
lular tight junction complexes  [30, 31] .
 The data obtained in our in vitro experiments suggest 
that the novel LMW HA may be associated with better 
anti-wrinkle properties in contrast to high-molecular-
weight HA based on improved skin penetration. Clinical 
data elucidating the clinical effects of topically applied 
HA of differing molecular weight support our hypothesis 
(data not published yet). HA is a substance with various 
physiological functions in different cell and tissue types. 
Clearly, one of its major functions in skin is to constitute 
the structural backbone of the dermal extracellular ma-
trix promoting proper tissue architecture. Secondly, it 
binds large amounts of water, thereby keeping the dermal 
skin layer properly moisturized. Apart from these well-
characterized functions, a growing number of studies 
suggest that HA also participates in different cellular 
functions, including regulation of metabolite diffusion, 
cell migration, cell signaling, cell proliferation and dif-
ferentiation, wound healing, cell adhesion, angiogenesis 
and inflammation  [32] . Although the largest amount of 
skin HA is present in the dermis, significant amounts 
could also be detected in the epidermis, in particular in 
the upper spinous and granular layers  [33–35] , but also in 
the stratum corneum  [36] . It is assumed that HA contrib-
utes to maintenance of epidermal skin hydration. Other 
functions of epidermal HA might include regulation of 
cell mitosis (basal layer) as well as recruitment of Langer-
hans cells via their CD44 receptors  [37, 38] and wound 
healing/regeneration processes  [34] . Notably, HA levels 
were found to be greatly reduced in aged epidermis, but 
not in aged dermis. This age-related epidermal HA defi-
ciency might be compensated by topical delivery via cos-
metic formulations containing HA.
 Conclusions 
 Beneficial features of HA may be related to particular 
molecular sizes. We found that an LMW HA of approx-
imately 50 kDa penetrates the skin better than larger-
sized HA and, accordingly, influences the expression of 
many genes including those contributing to keratinocyte 
differentiation and formation of intercellular tight junc-
tion complexes which are reported to be reduced in aged 
and photodamaged skin. This can be utilized without 
running the risk of increased proinflammatory activity.
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